• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码 RNA 在肝细胞癌代谢重编程调控中的作用及其机制。

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.

机构信息

Department of Liver Surgery & Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.

Department of Postanesthesia Care Unit & Surgical Anesthesia Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Int J Cancer. 2022 Aug 1;151(3):337-347. doi: 10.1002/ijc.34040. Epub 2022 May 11.

DOI:10.1002/ijc.34040
PMID:35460073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325518/
Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Metabolic reprogramming is considered to be an important hallmark of cancer. Emerging studies have demonstrated that noncoding RNAs (ncRNAs) are closely associated with metabolic reprogramming of HCC. NcRNAs can directly regulate the expressions or functions of metabolic enzymes or indirectly regulate the metabolism of HCC cells through some vital signaling pathways. Until now, the mechanisms of HCC development and progression remain largely unclear, and understanding the regulatory mechanism of ncRNAs on metabolic reprogramming of HCC may provide an important basis for breakthrough progress in the treatment of HCC. In this review, we summarize the ncRNAs involved in regulating metabolic reprogramming of HCC. Specifically, the regulatory roles of ncRNAs in glucose, lipid and amino acid metabolism are elaborated. In addition, we discuss the molecular mechanism of ncRNAs in regulation of metabolic reprogramming and possible therapeutic strategies that target the metabolism of cancer cells by modulating the expressions of specific ncRNAs.

摘要

肝细胞癌(HCC)是最常见的原发性肝癌。代谢重编程被认为是癌症的一个重要标志。新兴的研究表明,非编码 RNA(ncRNA)与 HCC 的代谢重编程密切相关。ncRNA 可以直接调节代谢酶的表达或功能,或通过一些重要的信号通路间接调节 HCC 细胞的代谢。到目前为止,HCC 发展和进展的机制在很大程度上仍不清楚,了解 ncRNA 对 HCC 代谢重编程的调控机制可能为 HCC 治疗的突破性进展提供重要依据。在这篇综述中,我们总结了参与调节 HCC 代谢重编程的 ncRNA。具体来说,阐述了 ncRNA 在葡萄糖、脂质和氨基酸代谢中的调节作用。此外,我们还讨论了 ncRNA 调节代谢重编程的分子机制,以及通过调节特定 ncRNA 的表达来靶向癌细胞代谢的可能治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/f77d7986776e/IJC-151-337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/ae330cb15e3a/IJC-151-337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/f107909522c3/IJC-151-337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/f77d7986776e/IJC-151-337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/ae330cb15e3a/IJC-151-337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/f107909522c3/IJC-151-337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e92/9325518/f77d7986776e/IJC-151-337-g003.jpg

相似文献

1
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.非编码 RNA 在肝细胞癌代谢重编程调控中的作用及其机制。
Int J Cancer. 2022 Aug 1;151(3):337-347. doi: 10.1002/ijc.34040. Epub 2022 May 11.
2
Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review).非编码 RNA 在膀胱癌代谢重编程调控中的作用及机制(综述)。
Int J Mol Med. 2023 Sep;52(3). doi: 10.3892/ijmm.2023.5282. Epub 2023 Jul 21.
3
ncRNA-mediated fatty acid metabolism reprogramming in HCC.非编码RNA介导的肝癌脂肪酸代谢重编程
Trends Endocrinol Metab. 2023 May;34(5):278-291. doi: 10.1016/j.tem.2023.02.007. Epub 2023 Mar 6.
4
[Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].长链非编码RNA在原发性肝细胞癌脂质代谢重编程中的研究进展
Zhonghua Gan Zang Bing Za Zhi. 2024 Feb 20;32(2):180-185. doi: 10.3760/cma.j.cn501113-20240117-00034.
5
Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.非编码 RNA 介导的肝癌中 PI3K/Akt 通路调控:治疗展望。
Pathol Res Pract. 2024 Jun;258:155303. doi: 10.1016/j.prp.2024.155303. Epub 2024 Apr 27.
6
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.非编码 RNA 在肝细胞癌中的作用:分子功能与病理意义。
Nat Rev Gastroenterol Hepatol. 2018 Mar;15(3):137-151. doi: 10.1038/nrgastro.2017.169. Epub 2018 Jan 10.
7
Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism.非编码 RNA 在肝细胞癌转移中的作用:显著的标志物和潜在的致癌机制。
Comput Biol Med. 2024 Sep;180:108867. doi: 10.1016/j.compbiomed.2024.108867. Epub 2024 Jul 31.
8
Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.长链非编码 RNA LINC01234 通过协调天冬氨酸代谢重编程促进肝细胞癌进展。
Mol Ther. 2022 Jun 1;30(6):2354-2369. doi: 10.1016/j.ymthe.2022.02.020. Epub 2022 Feb 19.
9
Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.非编码RNA在肿瘤相关巨噬细胞代谢重编程中的新作用
Immunol Lett. 2021 Apr;232:27-34. doi: 10.1016/j.imlet.2021.02.003. Epub 2021 Feb 9.
10
Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).肝细胞癌代谢重编程的研究进展(综述)。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13255. Epub 2024 May 31.

引用本文的文献

1
Mitochondrial dysfunction in hepatocellular carcinoma: from metabolism to targeted therapies.肝细胞癌中的线粒体功能障碍:从代谢到靶向治疗
Mol Cell Biochem. 2025 Aug 30. doi: 10.1007/s11010-025-05377-x.
2
Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma.免疫相关代谢基因的特征可预测肝细胞癌的预后。
Front Immunol. 2024 Nov 25;15:1481331. doi: 10.3389/fimmu.2024.1481331. eCollection 2024.
3
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.

本文引用的文献

1
Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system.靶向丙酮酸羧化酶的长链非编码RNA RP11-241J12.3通过破坏丙酮酸代谢和DNA错配修复系统促进肝细胞癌的侵袭性。
Mol Biomed. 2022 Feb 5;3(1):4. doi: 10.1186/s43556-021-00065-w.
2
Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo.特异性 LINC01146,一种有前途的预后指标,在体外和体内均抑制肝癌细胞的恶性表型。
J Transl Med. 2022 Jan 31;20(1):57. doi: 10.1186/s12967-021-03225-2.
3
Circ_0001944靶向miR-1292-5p/FBLN2轴,通过抑制铁死亡促进肝细胞癌对索拉非尼的耐药性。
Immunotargets Ther. 2024 Nov 26;13:643-659. doi: 10.2147/ITT.S463556. eCollection 2024.
4
Circ_0084615 promotes epithelial-mesenchymal transition-mediated tumor progression in hepatocellular carcinoma.Circ_0084615促进肝细胞癌中上皮-间质转化介导的肿瘤进展。
Ann Gastroenterol Surg. 2024 Jun 3;8(6):1107-1117. doi: 10.1002/ags3.12828. eCollection 2024 Nov.
5
Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma.脂质纳米粒共递送喜树碱和 miR-145 用于 MRI 可见的肝细胞癌靶向治疗。
J Exp Clin Cancer Res. 2024 Aug 30;43(1):247. doi: 10.1186/s13046-024-03167-9.
6
New HCC Subtypes Based on CD8 Tex-Related lncRNA Signature Could Predict Prognosis, Immunological and Drug Sensitivity Characteristics of Hepatocellular Carcinoma.基于CD8 Tex相关lncRNA特征的肝癌新亚型可预测肝细胞癌的预后、免疫及药物敏感性特征
J Hepatocell Carcinoma. 2024 Jul 5;11:1331-1355. doi: 10.2147/JHC.S459150. eCollection 2024.
7
Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).肝细胞癌代谢重编程的研究进展(综述)。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13255. Epub 2024 May 31.
8
Circular RNAs and the regulation of gene expression in diabetic nephropathy (Review).环状 RNA 与糖尿病肾病中的基因表达调控(综述)。
Int J Mol Med. 2024 May;53(5). doi: 10.3892/ijmm.2024.5368. Epub 2024 Mar 22.
9
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming.非编码RNA在癌症代谢重编程中的作用及分子机制。
Cancer Cell Int. 2024 Jan 18;24(1):37. doi: 10.1186/s12935-023-03186-0.
10
RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.RP11-495P10.1 通过 PDK1/PDH 轴调节葡萄糖代谢重编程和 NR4A3 启动子乙酰化促进 HCC 细胞增殖。
Acta Biochim Biophys Sin (Shanghai). 2024 Jan 25;56(1):44-53. doi: 10.3724/abbs.2023242.
Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma.
生物信息学分析和实验验证五个与代谢相关的长链非编码 RNA 作为肝细胞癌的预后模型。
Medicine (Baltimore). 2022 Jan 28;101(4):e28694. doi: 10.1097/MD.0000000000028694.
4
Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.长链非编码 RNA (lncRNA) CYTOR 通过靶向 microRNA-125a-5p/LASP1 轴促进肝癌增殖。
Bioengineered. 2022 Feb;13(2):3666-3679. doi: 10.1080/21655979.2021.2024328.
5
circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p/methyl-DNA-binding domain protein 2 axis.circKCNN2 通过调控 miR-520c-3p/甲基化 DNA 结合蛋白 2 轴至少部分抑制肝癌的复发。
Clin Transl Med. 2022 Jan;12(1):e662. doi: 10.1002/ctm2.662.
6
CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma.环状RPN2抑制肝细胞癌的有氧糖酵解和转移。
Cancer Res. 2022 Mar 15;82(6):1055-1069. doi: 10.1158/0008-5472.CAN-21-1259.
7
CCT3- axis regulates hepatocarcinogenic lipid metabolism.CCT3轴调节肝癌发生过程中的脂质代谢。
Gut. 2022 Jan 12;71(10):2081-92. doi: 10.1136/gutjnl-2021-325109.
8
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma.环状 RNA MRPS35 促进肝癌的恶性进展和顺铂耐药性。
Mol Ther. 2022 Jan 5;30(1):431-447. doi: 10.1016/j.ymthe.2021.08.027. Epub 2021 Aug 25.
9
A noncoding RNA modulator potentiates phenylalanine metabolism in mice.一种非编码 RNA 调节剂可增强小鼠苯丙氨酸代谢。
Science. 2021 Aug 6;373(6555):662-673. doi: 10.1126/science.aba4991.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.